Raising awareness is key to saving lives. HERA is committed to informing women, the people who love them and the doctors who treat them about the symptoms of the disease and what they can do if they suspect ovarian cancer
Speak up. Speak Out. A simple email of the information below will raise awareness. Be a myth buster – make sure all your friends know the symptoms of this disease. It is not a silent killer.
Need inspiration? Click here to watch Why We Climb and learn what we’re all about.
Ovarian cancer is not an uncommon disease. It is the fifth leading cause of cancer death among women and kills more women than all the other reproductive cancers combined.
Ninety percent of women who get the disease have no family history.
Ovarian cancer has symptoms, even early stage disease. According to a recent study by Barbara Goff, only 11% of women with early stage disease had no symptoms.
There is no reliable test for ovarian cancer like the Pap smear for cervical cancer or the mammogram for breast cancer. Over 78% of the women diagnosed this year will be diagnosed after the disease has spread when the chance for survival is less than 20%.
When ovarian cancer is caught early, it is highly curable.
There is no screening method for early detection for ovarian cancer. Pap smears test only for cervical cancer. The symptoms of ovarian cancer are vague and often overlooked, leading to later detection:
Any woman may have these symptoms for reasons not related to ovarian cancer. However, if these symptoms are new and unusual and persist daily for more than two weeks, a woman should see her doctor, preferably a gynecologist, and should ask about ovarian cancer. A transvaginal ultrasound and CA125 blood test may be necessary. If ovarian cancer is suspected, see a gynecologic oncologist immediately. (Source: Ovarian Cancer Research Fund)
Click here to learn more about ovarian cancer symptoms.
The mission of the HERA Ovarian Cancer Foundation is to eliminate ovarian cancer by promoting Health, Empowerment, Research, and Awareness.
© 2019 HERA Women’s Cancer Foundation